Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-10-28
1995-08-29
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544267, 544268, 544271, 544272, 536 2762, A61K 3152, C07D47306, C07D47308, C07D51900
Patent
active
054460468
ABSTRACT:
Adenosine and xanthine derivatives, and compositions comprising those compounds, are potent selective agonists and antagonists of adenosine receptors. The derivatives and composition are used to treat conditions, including certain cardiac arrhythmias.
REFERENCES:
patent: 3998953 (1976-12-01), Konz
patent: 4364922 (1982-12-01), Berne et al.
patent: 4713455 (1987-12-01), Furrer
patent: 4980379 (1990-12-01), Belardinelli et al.
patent: 5288721 (1994-02-01), Klein
Jacobsen, J Med Chem 35, 407 (1992).
Belardinelli, L. et al. (1989) "The Cardiac Effects of Adenosine" Progress in Cardiovascular Diseases 32:73-97.
Belardinelli, L. et al. (1990) "Cardiac Electrophysiology and Pharmacology of Adenosine" J. Cardiovasc. Electrophysiol. 1:327-339.
Olsson, R. A., J. D. Pearson (1990) "Cardiovascular Purinoceptors" Physiological Reviews 70:761-845.
Baker Stephen
Belardinelli Luiz
Olsson Ray
Scammells Peter J.
Berch Mark L.
University of Florida Research Foundation
LandOfFree
A1 adenosine receptor agonists and antagonists as diuretics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A1 adenosine receptor agonists and antagonists as diuretics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A1 adenosine receptor agonists and antagonists as diuretics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1819601